[EN] HSP-90 BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE I? THE TREATMENT AND PREVENTION OF FUNGAL INFECTIONS<br/>[FR] COMPOSÉS DE LIAISON À HSP-90, COMPOSITIONS DE CES COMPOSÉS, ET UTILISATIONS DE CES COMPOSÉS POUR LE TRAITEMENT ET LA PRÉVENTION D'INFECTIONS FONGIQUES
申请人:PHARMASCIENCE INC
公开号:WO2012126084A1
公开(公告)日:2012-09-27
The invention relates to therapeutic compounds that bind to HSP90. The compounds disclosed herein bind HSP90 and alter the chaperoning capability of HSP90 proteins. The invention also relates to pharmaceutical compositions comprising these compounds, and methods of treating or preventing fungal infections.
[Object]: To provide a compound having a novel structure effective against
Hemophilus influenzae
and erythromycin resistant bacteria (for example, resistant pneumococci and streptococci) as well as against conventional erythromycin sensitive bacteria.
[Solution]: A novel 10a-azalide compound represented by the formula (I), a pharmaceutically acceptable salt thereof or a solvate thereof, or an intermediate for the preparation of the same. The compound of the present invention has superior antibacterial activity against
Hemophilus influenzae
, erythromycin resistant pneumococci and the like, and therefore, the compound can be used as a therapeutic agent of infectious diseases.
Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.